Alx Oncology Holdings (ALXO) Total Liabilities (2019 - 2026)

Alx Oncology Holdings (ALXO) has 8 years of Total Liabilities data on file, last reported at $27.0 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities fell 17.25% year-over-year to $27.0 million; the trailing twelve-month figure through Mar 2026 stood at $27.0 million (down 17.25% YoY), and the FY2025 full-year result was $33.1 million, down 3.2% from the prior year.
• Total Liabilities declined to $27.0 million in Q1 2026, from $33.1 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $55.3 million in Q2 2024 to a low of $20.1 million in Q1 2022.
• A 5-year average of $38.1 million and a median of $34.2 million in 2024 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities surged 151.11% in 2022 and slumped 44.11% in 2025, its largest moves.
• Tracing ALXO's Total Liabilities over 5 years: stood at $43.0 million in 2022, then advanced by 22.81% to $52.8 million in 2023, then slumped by 35.36% to $34.2 million in 2024, then slipped by 3.2% to $33.1 million in 2025, then retreated by 18.4% to $27.0 million in 2026.
• Business Quant data shows ALXO's Total Liabilities at $27.0 million in Q1 2026, $33.1 million in Q4 2025, and $37.9 million in Q3 2025.